Meeting
2023 ASCO Genitourinary Cancers Symposium
Biochemical disease control outcomes of stereotactic body radiation therapy (SBRT) or moderate hypo-fractionation (HFRT) for low- and intermediate-risk prostate cancer (PrCa): Retrospective analysis of 12 years of experience at two Canadian cancer centers.
Authors
Hsin-pei (Spencer) Hu
McMaster University and Juravinski Cancer Centre, Hamilton, ON, Canada
Hsin-pei (Spencer) Hu , Mohammad Gouran-Savadkoohi , Gregory Anagnostopoulos , Ian S. Dayes , Adrian Ishkanian , Abhirami Hallock , Thomas B Corbett , Himanshu Lukka , Kimmen Quan , Kara Schnarr , David Cuthbert , Mira Goldberg , Theodoros Tsakiridis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 363)
DOI
10.1200/JCO.2023.41.6_suppl.363
Abstract #
363
Poster Bd #
N1
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
Early surrogate measures for ablative therapies for intermediate-risk prostate cancer patients.
First Author: Rachel Glicksman
Poster
2016 ASCO Annual Meeting
Does short-term androgen depletion add to high dose radiotherapy (80 Gy) in localized intermediate risk prostate cancer? Final analysis of GETUG 14 randomized trial (EU-20503/NCT00104741).
First Author: Bernard M. Dubray
Poster
2023 ASCO Genitourinary Cancers Symposium
Biochemical recurrence (BCR) surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate (BCRSCRAP): A meta-analysis from MARCAP Consortium.
First Author: Soumyajit Roy
Poster
2020 Genitourinary Cancers Symposium
Safety and outcome of stereotactic body radiation therapy (SBRT) with rectal hydrogel spacer for prostate cancer.
First Author: Lily Chen